Genomic and geographical structure of human cytomegalovirus
Journal article
Charles, J., Venturini, C., Gantt, S., Atkinson, C., Griffiths, P., Goldstein, R.S. and Breuer, J. (2023). Genomic and geographical structure of human cytomegalovirus. PNAS. 120 (30), p. e2221797120. https://doi.org/10.1073/pnas.2221797120
Authors | Charles, J., Venturini, C., Gantt, S., Atkinson, C., Griffiths, P., Goldstein, R.S. and Breuer, J. |
---|---|
Abstract | Human cytomegalovirus (CMV) has infected humans since the origin of our species and currently infects most of the world’s population. Variability between CMV genomes is the highest of any human herpesvirus, yet large portions of the genome are conserved. Here, we show that the genome encodes 74 regions of relatively high variability each with 2 to 8 alleles. We then identified two patterns in the CMV genome. Conserved parts of the genome and a minority (32) of variable regions show geographic population structure with evidence for African or European clustering, although hybrid strains are present. We find no evidence that geographic segregation has been driven by host immune pressure affecting known antigenic sites. Forty-two variable regions show no geographical structure, with similar allele distributions across different continental populations. These “nongeographical” regions are significantly enriched for genes encoding immunomodulatory functions suggesting a core functional importance. We hypothesize that at least two CMV founder populations account for the geographical differences that are largely seen in the conserved portions of the genome, although the timing of separation and direction of spread between the two are not clear. In contrast, the similar allele frequencies among 42 variable regions of the genome, irrespective of geographical origin, are indicative of a second evolutionary process, namely balancing selection that may preserve properties critical to CMV biological function. Given that genetic differences between CMVs are postulated to alter immunogenicity and potentially function, understanding these two evolutionary processes could contribute important information for the development of globally effective vaccines and the identification of novel drug targets. |
Year | 2023 |
Journal | PNAS |
Journal citation | 120 (30), p. e2221797120 |
Publisher | Proceedings of the National Academy of Sciences |
ISSN | 1091-6490 |
Digital Object Identifier (DOI) | https://doi.org/10.1073/pnas.2221797120 |
Publication dates | |
17 Jul 2023 | |
Publication process dates | |
Accepted | 16 Jun 2023 |
Deposited | 20 Jul 2023 |
Publisher's version | License File Access Level Open |
Accepted author manuscript | License File Access Level Open |
https://openresearch.lsbu.ac.uk/item/947zx
Download files
Publisher's version
pnas.2221797120.pdf | ||
License: CC BY 4.0 | ||
File access level: Open |
Accepted author manuscript
113
total views116
total downloads4
views this month8
downloads this month